| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $117.80 | $23.77 | 395.69% | 222.26x | 56.06x | 14.94x | 18.04x | 1.61x | $106.92M | 0.86% | $705.78M | 6.70 | $12.63B | 1,610.25 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $26.09 | $8.12 | 221.35% | 124.24x | 58.33x | 7.34x | 14.87x | 1.06x | $39.15M | 1.15% | $220.58M | 1.69 | $3.36B | 74.00 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $78.53 | $17.12 | 358.67% | 73.39x | 67.18x | 7.25x | 9.37x | 1.87x | $182.84M | 3.00% | $654.15M | 8.43 | $5.96B | 49.69 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $223.82 | $79.54 | 181.38% | 36.69x | 33.19x | 6.22x | 22.12x | 1.26x | $793.95M | 2.65% | $1.35B | 10.14 | $31.23B | 26.48 | ||
| VCEL | VERICEL CORP | $40.30 | $7.90 | 409.91% | 83.96x | 72.00x | 6.72x | 5.58x | 2.06x | $61.66M | 3.00% | $370.04M | 7.25 | $2.03B | 46.11 | ||
| HALO | HALOZYME THERAPEUTICS INC | $109.62 | $70.34 | 55.83% | 30.79x | 12.14x | 7.73x | 86.68x | 0.59x | $806.22M | 6.27% | $143.54M | 1.22 | $14.42B | 20.08 | ||
| RPRX | ROYALTY PHARMA PLC | $56.57 | $35.77 | 58.17% | 30.09x | 10.34x | 9.93x | 3.32x | 0.61x | $2.92B | 11.61% | $9.79B | 21.99 | $40.68B | 34.59 | ||
| KRYS | KRYSTAL BIOTECH INC | $321.16 | $83.00 | 286.94% | 38.83x | 41.14x | 21.53x | 6.99x | 2.07x | $257.78M | 2.72% | $1.36B | 46.03 | $9.09B | 38.95 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $54.38 | $18.42 | 195.20% | 143.11x | 18.79x | 3.09x | 1.67x | 0.95x | $738.18M | 7.02% | $6.32B | 32.68 | $13.84B | 35.88 | ||
| TGTX | TG THERAPEUTICS INC | $54.34 | $22.16 | 145.19% | 17.64x | 54.68x | 9.63x | 13.77x | 1.96x | $17.39M | 0.23% | $604.08M | 4.26 | $8.59B | 61.68 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $10.39 | $7.52 | 38.09% | 10.94x | 9.55x | 4.52x | 2.83x | 0.95x | $82.01M | 13.34% | $217.65M | 3.68 | $473.17M | 6.12 | ||
| ADMA | ADMA BIOLOGICS INC | $10.31 | $6.90 | 49.46% | 14.32x | 12.96x | 4.59x | 5.66x | 0.83x | $116.47M | 4.95% | $408.21M | 1.79 | $2.37B | 10.18 | ||
| EXEL | EXELIXIS INC | $59.51 | $29.66 | 100.63% | 18.09x | 17.99x | 6.13x | 8.00x | 1.19x | $1.17B | 7.86% | $1.84B | 7.35 | $14.63B | 13.45 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $210.39 | $178.21 | 18.06% | 13.79x | 8.23x | 2.89x | 2.84x | 0.57x | $1.62B | 12.18% | $4.80B | 75.98 | $16.43B | 10.17 | ||
| MDXG | MIMEDX GROUP INC | $4.69 | $1.26 | 272.64% | 117.25x | -27.05x | 1.95x | 3.16x | 1.27x | $44.50M | 6.42% | $216.00M | 1.46 | $564.98M | 24.77 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $303.53 | $84.87 | 257.64% | 30.14x | 32.13x | 20.96x | 6.25x | 2.28x | $130.62M | 2.15% | $967.52M | 48.22 | $6.18B | 22.14 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $485.22 | $146.67 | 230.82% | 28.00x | 25.35x | 9.78x | 6.07x | 2.10x | $3.80B | 3.08% | $20.25B | 79.81 | $118.82B | 21.59 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $37.03 | $29.75 | 24.47% | 11.79x | 8.88x | 2.23x | 2.16x | 0.70x | $354.90M | 16.54% | $999.24M | 17.25 | $1.76B | 6.29 | ||
| UTHR | UNITED THERAPEUTICS CORP | $543.40 | $186.47 | 191.42% | 17.97x | 20.33x | 7.34x | 3.64x | 3.30x | $1.09B | 4.72% | $6.40B | 150.24 | $21.50B | 12.83 | ||
| TECH | BIO-TECHNE CORP | $72.48 | $16.10 | 350.25% | 61.95x | 34.88x | 9.30x | 5.39x | 1.97x | $263.22M | 2.33% | $2.11B | 13.52 | $11.39B | 32.76 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $753.12 | $423.02 | 78.03% | 17.96x | 13.42x | 4.98x | 2.45x | 0.95x | $3.76B | 4.86% | $31.71B | 308.48 | $77.79B | 13.53 | ||
| VCYT | VERACYTE INC | $43.11 | $11.59 | 271.84% | 29.94x | 22.17x | 6.14x | 2.50x | 2.51x | $165.99M | 4.82% | $1.39B | 17.36 | $3.20B | 22.94 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.15 | $1.37 | -16.19% | 8.21x | -2.59x | 1.42x | 1.52x | 0.46x | $19.58M | 29.39% | $44.20M | 0.76 | $18.24M | 2.39 | ||
| INCY | INCYTE CORP | $108.62 | $58.24 | 86.52% | 13.38x | 30.64x | 3.74x | 3.47x | 1.50x | $1.92B | 8.82% | $6.34B | 31.66 | $18.07B | 8.74 |